Chimerix, Inc. | TalkMarkets

Latest Posts

Medical Device Stocks To Beat Estimates This Earnings Season

Article By: Zacks Investment Research

Wednesday, April 19, 2017 4:16 AM EDT

LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease. The past six months were very favorable for the stock rising almost 29%.

In this article: LMAT, CMRX, HRC

Read

5 Breakout Stocks For Superior Returns

Article By: Swarup Gupta

Friday, February 10, 2017 10:50 AM EDT

Utilizing a breakout investment strategy is a favored choice of active investors who are content only with returns superior to most other investments.

In this article: GNK, CBAY, CMRX, SMMT, MODN

Read

Chimerix Announces Phase 3 Trial Failure

Article By: Terry Chrisomalis

Monday, February 22, 2016 8:16 PM EDT

Chimerix halts two phase 3 trials after failing to meet primary endpoint.

In this article: CMRX

Read

Insider Trading Report Edition 289: Notable Buys And Sales

Article By: Asif Suria

Monday, January 4, 2016 6:26 AM EDT

Insider buying decreased last week with insiders buying $42.25m of stock compared to $60.29m in the week prior. Selling also decreased with insiders selling $359.11m of stock last week compared to $522.92m in the week prior.